TradingView
Market_Referee
2019年9月13日下午1點05分

Ritter Pharmaceuticals basically dead? 看空

描述

-75% Ritter Pharmaceuticals Inc -after the company's Phase 3 trial of RP-G28 for lactose intolerance failed to demonstrate statistical significance in its pre-specified endpoint
更多